Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Martini

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Molecular Therapy. Methods & Clinical Development|February 14, 2024
Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of GalactosemiaBijina Balakrishnan, Xinhua Yan, Marshall D McCue, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 19, 2023
Tyrosine-Mutant AAV8 Vector Mediated Efficient and Safe Gene Transfer of Pigment Epithelium-Derived Factor to Mouse LungsDébora P Ferreira, Sabrina V Martini, Helena A Oliveira, et al.
Nature Communications|May 7, 2024
Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuriaRena Baek, Kimberly Coughlan, Lei Jiang, et al.
British Journal of Cancer|May 14, 2009
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismB Cambien, B F Karimdjee, P Richard-Fiardo, et al.
Molecular Genetics and Metabolism|December 29, 2022
Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine modelXue-Jun Zhao, Ai-Walid Mohsen, Stephanie Mihalik, et al.
Respiratory Physiology & Neurobiology|October 24, 2007
Does the use of recombinant AAV2 in pulmonary gene therapy damage lung function?Roberta M Lassance, Caroline P Pássaro, Sabrina V Martini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 22, 2014
DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthmaAdriana L da Silva, Sabrina V Martini, Soraia C Abreu, et al.
American Journal of Human Genetics|March 19, 2019
Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human PrimatesXuling Zhu, Ling Yin, Matt Theisen, et al.
Molecular Therapy. Nucleic Acids|August 30, 2021
mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacksDaniel Jericó, Karol M Córdoba, Lei Jiang, et al.
Human Molecular Genetics|May 10, 2023
Messenger RNA rescues medium-chain acyl-CoA dehydrogenase deficiency in fibroblasts from patients and a murine modelXue-Jun Zhao, Ai-Walid Mohsen, Stephanie Mihalik, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Molecular Therapy. Methods & Clinical Development|February 14, 2024
Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of GalactosemiaBijina Balakrishnan, Xinhua Yan, Marshall D McCue, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 19, 2023
Tyrosine-Mutant AAV8 Vector Mediated Efficient and Safe Gene Transfer of Pigment Epithelium-Derived Factor to Mouse LungsDébora P Ferreira, Sabrina V Martini, Helena A Oliveira, et al.
Nature Communications|May 7, 2024
Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuriaRena Baek, Kimberly Coughlan, Lei Jiang, et al.
British Journal of Cancer|May 14, 2009
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismB Cambien, B F Karimdjee, P Richard-Fiardo, et al.
Molecular Genetics and Metabolism|December 29, 2022
Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine modelXue-Jun Zhao, Ai-Walid Mohsen, Stephanie Mihalik, et al.
Respiratory Physiology & Neurobiology|October 24, 2007
Does the use of recombinant AAV2 in pulmonary gene therapy damage lung function?Roberta M Lassance, Caroline P Pássaro, Sabrina V Martini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 22, 2014
DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthmaAdriana L da Silva, Sabrina V Martini, Soraia C Abreu, et al.
American Journal of Human Genetics|March 19, 2019
Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human PrimatesXuling Zhu, Ling Yin, Matt Theisen, et al.
Molecular Therapy. Nucleic Acids|August 30, 2021
mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacksDaniel Jericó, Karol M Córdoba, Lei Jiang, et al.
Human Molecular Genetics|May 10, 2023
Messenger RNA rescues medium-chain acyl-CoA dehydrogenase deficiency in fibroblasts from patients and a murine modelXue-Jun Zhao, Ai-Walid Mohsen, Stephanie Mihalik, et al.
Pageof 12